Travere Therapeutics Inc (TVTX) — Capital Reinvestment Ratio
Latest as of December 2025:
0.01x
Travere Therapeutics Inc (TVTX) has a Capital Reinvestment Ratio of 0.01x as of December 2025, meaning it reinvests 0% of its operating cash flow ($60.68 Million) in capital expenditures ($375.00K). See TVTX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$60.68 Million
USD
Capital Expenditures
$375.00K
USD
Data as of
Dec 2025
Most recent filing
Travere Therapeutics Inc Capital Reinvestment Ratio (2017–2025)
This chart tracks Travere Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Travere Therapeutics Inc (2017–2025)
Year-by-year Capital Reinvestment Ratio for Travere Therapeutics Inc from 2017 to 2025. For live market cap and broader valuation context, see Travere Therapeutics Inc (TVTX) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.54x | $37.78 Million | $58.16 Million | ▼ -18.7% |
| 2017 | 1.89x | $7.40 Million | $14.01 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow